OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Current and Emerging Therapies in NSCLC

home / peer-exchange / nsclc-therapies
Case Study: Treating an Elderly Patient With Squamous NSCLC

EP. 1: Case Study: Treating an Elderly Patient With Squamous NSCLC

August 21st 2013
Case Study: Maintenance Therapy in Squamous NSCLC

EP. 2: Case Study: Maintenance Therapy in Squamous NSCLC

August 21st 2013
Case Study: Mutation-Negative Patient With Adenocarcinoma

EP. 3: Case Study: Mutation-Negative Patient With Adenocarcinoma

August 21st 2013
PRONOUNCE Trial: Two Drug Versus Three Drug Regimens

EP. 4: PRONOUNCE Trial: Two Drug Versus Three Drug Regimens

August 21st 2013
Case Study: Second-Line Treatment of Adenocarcinoma

EP. 5: Case Study: Second-Line Treatment of Adenocarcinoma

August 21st 2013
Case Study: MET and ALK Targeted Therapies in NSCLC

EP. 6: Case Study: MET and ALK Targeted Therapies in NSCLC

August 21st 2013
Case Study: Progression on ALK Inhibitors in NSCLC

EP. 7: Case Study: Progression on ALK Inhibitors in NSCLC

August 21st 2013
Case Study: Treating KRAS-Mutant Adenocarcinoma

EP. 8: Case Study: Treating KRAS-Mutant Adenocarcinoma

August 21st 2013
Targeting the Immune System in Non-Small Cell Lung Cancer

EP. 9: Targeting the Immune System in Non-Small Cell Lung Cancer

August 21st 2013
Novel Immunotherapy Combinations in NSCLC

EP. 10: Novel Immunotherapy Combinations in NSCLC

August 21st 2013
GALAXY-1 Trial: Investigation of Hsp90 Inhibition in NSCLC

EP. 11: GALAXY-1 Trial: Investigation of Hsp90 Inhibition in NSCLC

August 21st 2013
Selecting a First-Line EGFR Inhibitor in NSCLC

EP. 12: Selecting a First-Line EGFR Inhibitor in NSCLC

August 21st 2013
Conclusion: Final Thoughts on Treatment Advances in NSCLC

EP. 13: Conclusion: Final Thoughts on Treatment Advances in NSCLC

August 21st 2013

Latest Conference Coverage

Poll Results Punctuate Key Lung Cancer Abstracts Driving Intrigue Ahead of ASCO 2025

Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study

Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial

Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact